Effects of Rurality on Distance and Time Traveled to Receive Vaccination Against Mpox-New Mexico and Idaho 2022-2023

Anna M Stadelman-Behar; Megan E Cahill; Katherine Newell; Marla Sievers; Mika Gehre; Kris K Carter; Daniel M Sosin; Elizabeth A Torrone

doi:10.1097/OLQ.0000000000001904

Effects of Rurality on Distance and Time Traveled to Receive Vaccination Against Mpox-New Mexico and Idaho 2022-2023

Sex Transm Dis. 2024 Feb 1;51(2):102-104. doi: 10.1097/OLQ.0000000000001904. Epub 2023 Nov 16.

Authors

Anna M Stadelman-Behar, Megan E Cahill, Katherine Newell¹, Marla Sievers², Mika Gehre², Kris K Carter, Daniel M Sosin², Elizabeth A Torrone³

Affiliations

¹ From the Epidemic Intelligence Service, Division of Workforce Development, Centers for Disease Control and Prevention, Atlanta, GA.
² Epidemiology Response Division, New Mexico Department of Health, Santa Fe, NM.
³ Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD & TB Prevention, Atlanta, GA.

PMID: 37977191
PMCID: PMC10843776 (available on 2025-02-01)
DOI: 10.1097/OLQ.0000000000001904

Abstract

We compared mpox vaccination access between urban and rural residents who received ≥1 JYNNEOS dose using immunization data in Idaho and New Mexico. Rural residents traveled 5 times farther and 3 times longer than urban residents to receive mpox vaccination. Increasing mpox vaccine availability to health care facilities might increase uptake.

MeSH terms

Health Facilities
Humans
Idaho / epidemiology
Mpox (monkeypox)*
New Mexico / epidemiology
Smallpox Vaccine*
Vaccination

Substances

Smallpox Vaccine

Grants and funding

CC999999/ImCDC/Intramural CDC HHS/United States